Metabolomics Characterization of Biomarkers of Different Types of Myocardial Infarction in Different Time.
NCT ID: NCT04817748
Last Updated: 2021-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2020-11-17
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
NCT03076580
Plaque Stability and Metabolomics in Coronary Heart Disease
NCT05270330
Clinical Features and Linked MEchanisms in Acute Risk-free AMI
NCT06716177
Prospective Acute Myocardial Infarction Data Bank
NCT05121818
Prognostic Markers of Patients With STEMI
NCT03527940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute ST segment elevation myocardial infarction（STEMI）
the patients' coronary and venous blood were drawn for metabolomics study
No interventions assigned to this group
Acute non ST segment elevation myocardial infarction（NSTEMI）
the patients' coronary and venous blood were drawn for metabolomics study
No interventions assigned to this group
Acute myocardial infarction with no obstructive coronary atherosclerosis（MINOCA）
the patients' coronary and venous blood were drawn for metabolomics study
No interventions assigned to this group
Patients with normal coronary artery（NCA)
the patients' coronary and venous blood were drawn for metabolomics study
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Ischemic symptoms
2. New ischemic ECG changes, new ST-T changes or left bundle branch block（LBBB）.
3. Pathological Q wave formation in ECG
4. Imaging evidence showed new loss of myocardial activity or new regional wall motion abnormalities.
5. The thrombus was confirmed by coronary angiography. 3．The patient had chest pain symptoms, but coronary angiography showed normal coronary artery (such as intercostal neuralgia, cervical spondylosis, chest pain of unknown origin, etc.)
Exclusion Criteria
2. Surgical treatment was performed in the last three months.
3. Patients with a history of the following diseases or consider the diagnosis of the following diseases：Stress cardiomyopathy, myocarditis, pericarditis, pneumonia, pulmonary embolism, aortic dissection.
4. Severe heart failure, grade IV cardiac function.
5. Liver and kidney dysfunction.
6. blood-borne diseases, including HIV / AIDS, hepatitis B, hepatitis C, etc.
7. Patients with a history of malignancies, autoimmune diseases, severe infectious diseases and trauma.
8. Previous history of myocardial infarction and stroke.
20 Years
76 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai 10th People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ya-Wei Xu
cardiology department of shanghai 10th people's hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yi Zhang, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology, Shanghai Tenth People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yi Zhang
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCBDTMIDT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.